News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
61,182 Results
Type
Article (2919)
Company Profile (10)
Press Release (58253)
Section
Business (20580)
Career Advice (60)
Deals (3302)
Drug Delivery (2)
Drug Development (10226)
Employer Resources (1)
FDA (1376)
Job Trends (1529)
News (33743)
Policy (2221)
Tag
Academia (232)
Accelerated approval (1)
Adcomms (3)
Allergies (19)
Alliances (2246)
ALS (18)
Alzheimer's disease (179)
Antibody-drug conjugate (ADC) (12)
Approvals (1425)
Artificial intelligence (24)
Autoimmune disease (4)
Automation (1)
Bankruptcy (8)
Best Places to Work (1574)
BIOSECURE Act (1)
Biosimilars (10)
Biotechnology (8)
Bladder cancer (20)
Brain cancer (4)
Breast cancer (90)
Cancer (473)
Cardiovascular disease (32)
Career advice (43)
CAR-T (28)
Cell therapy (67)
Cervical cancer (6)
Clinical research (8621)
Collaboration (88)
Compensation (12)
Complete response letters (1)
COVID-19 (250)
CRISPR (5)
C-suite (15)
Cystic fibrosis (15)
Data (551)
Depression (9)
Diabetes (41)
Diagnostics (605)
Digital health (2)
Drug discovery (18)
Drug pricing (7)
Duchenne muscular dystrophy (31)
Earnings (16761)
Editorial (2)
Employer resources (1)
Events (9742)
Executive appointments (29)
FDA (1669)
Frontotemporal dementia (2)
Funding (82)
Gene editing (22)
Generative AI (2)
Gene therapy (64)
GLP-1 (77)
Government (219)
Grass and pollen (1)
Guidances (68)
Healthcare (1779)
Huntington's disease (2)
IgA nephropathy (4)
Immunology and inflammation (16)
Indications (7)
Infectious disease (275)
Inflammatory bowel disease (24)
Influenza (8)
Intellectual property (12)
Interviews (12)
IPO (2468)
IRA (5)
Job creations (79)
Job search strategy (32)
Labor market (2)
Layoffs (31)
Legal (297)
Liver cancer (12)
Lung cancer (67)
Lymphoma (32)
Manufacturing (12)
MASH (15)
Medical device (1430)
Medtech (1430)
Mergers & acquisitions (903)
Metabolic disorders (86)
Multiple sclerosis (19)
NASH (1)
Neurodegenerative disease (14)
Neuropsychiatric disorders (5)
Neuroscience (275)
NextGen: Class of 2025 (441)
Non-profit (193)
Obesity (32)
Opinion (17)
Ovarian cancer (22)
Pain (13)
Pancreatic cancer (10)
Parkinson's disease (20)
Patents (21)
Patient recruitment (25)
Peanut (14)
People (1967)
Pharmaceutical (4)
Phase I (2808)
Phase II (3838)
Phase III (3043)
Pipeline (403)
Policy (8)
Postmarket research (274)
Preclinical (1027)
Press Release (3)
Prostate cancer (24)
Psychedelics (10)
Radiopharmaceuticals (51)
Rare diseases (60)
Real estate (202)
Recruiting (1)
Regulatory (1997)
Reports (3)
Research institute (150)
Resumes & cover letters (21)
Rett syndrome (2)
RSV (13)
Schizophrenia (16)
Series A (15)
Series B (9)
Service/supplier (2)
Sickle cell disease (9)
Spinal muscular atrophy (22)
Sponsored (4)
Startups (206)
Stomach cancer (2)
Supply chain (1)
Vaccines (77)
Venture capitalists (5)
Weight loss (13)
Women's health (2)
Worklife (1)
Date
Today (26)
Last 7 days (190)
Last 30 days (560)
Last 365 days (4898)
2025 (1859)
2024 (5202)
2023 (5797)
2022 (6235)
2021 (6258)
2020 (5359)
2019 (3841)
2018 (2860)
2017 (2608)
2016 (1823)
2015 (2273)
2014 (1666)
2013 (980)
2012 (1031)
2011 (1201)
2010 (1023)
Location
Africa (34)
Alabama (6)
Alaska (1)
Arizona (29)
Asia (4058)
Australia (524)
California (825)
Canada (283)
China (85)
Colorado (27)
Connecticut (53)
Delaware (66)
Europe (8826)
Florida (130)
Georgia (28)
Idaho (2)
Illinois (95)
India (2)
Indiana (50)
Iowa (1)
Japan (44)
Kansas (1)
Kentucky (4)
Louisiana (4)
Maine (14)
Maryland (81)
Massachusetts (690)
Michigan (25)
Minnesota (42)
Missouri (10)
Montana (4)
Nebraska (1)
Nevada (13)
New Hampshire (11)
New Jersey (364)
New York (291)
North Carolina (112)
Northern California (391)
Ohio (26)
Oregon (3)
Pennsylvania (292)
Puerto Rico (3)
Rhode Island (1)
South America (59)
South Carolina (1)
Southern California (335)
Tennessee (8)
Texas (114)
United States (3474)
Utah (29)
Virginia (7)
Washington D.C. (5)
Washington State (95)
Wisconsin (6)
61,182 Results for "101".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Arbutus to Present Imdusiran and AB-101 Data at EASL Congress 2025
April 23, 2025
·
7 min read
Press Releases
Innovo Therapeutics Announces Positive Phase 1 Results for INV-101, a Novel Immuno-Metabolic Modulator for Autoimmune Diseases
May 12, 2025
·
2 min read
Press Releases
IPAX-Linz Study Reports Promising Efficacy for TLX101 Glioma Therapy Candidate
April 16, 2025
·
9 min read
Press Releases
Bright Minds Biosciences Announces Positive Findings from its DBA/2 Mouse Model Study Evaluating BMB-101
May 13, 2025
·
6 min read
Press Releases
SCG Announces Late-Breaking Clinical Data of SCG101 in HBV-Related Hepatocellular Carcinoma Presented at EASL 2025
May 8, 2025
·
5 min read
Press Releases
Bioxodes announces positive Phase 2a interim data for BIOX-101 in intracerebral hemorrhagic stroke patients
April 24, 2025
·
4 min read
Press Releases
Vascarta commences a Phase I clinical study of VAS101 in osteoarthritis
March 19, 2025
·
4 min read
Press Releases
Arbor Biotechnologies to Present Preclinical Data for ABO-101 in PH1 at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
May 13, 2025
·
4 min read
Press Releases
AviadoBio Announces Completion of Second Cohort in Phase 1/2 ASPIRE-FTD Clinical Trial Studying AVB-101 for FTD-GRN
May 1, 2025
·
4 min read
Press Releases
Sydnexis Announces Positive CHMP Opinion in Europe for SYD-101 for Slowing the Progression of Pediatric Myopia
April 1, 2025
·
3 min read
1 of 6,119
Next
